Next Article in Journal
Asymmetric Introgression in the Horticultural Living Fossil Cycas Sect. Asiorientales Using a Genome-Wide Scanning Approach
Next Article in Special Issue
Ovarian Cancer: Can Proteomics Give New Insights for Therapy and Diagnosis?
Previous Article in Journal
Endoplasmic Reticulum (ER) Stress Response and Its Physiological Roles in Plants
Previous Article in Special Issue
Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2013, 14(4), 8213-8227;

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Wallace Tumor Institute, 1824 6th Avenue South, Birmingham, AL 35233, USA
Author to whom correspondence should be addressed.
Received: 27 February 2013 / Revised: 28 March 2013 / Accepted: 1 April 2013 / Published: 15 April 2013
(This article belongs to the Special Issue Genes and Pathways in the Pathogenesis of Ovarian Cancer)
Full-Text   |   PDF [197 KB, uploaded 19 June 2014]


Ovarian cancer is the fifth most common cause of death due to cancer in women despite being the tenth in incidence. Unfortunately, the five-year survival rate is only 45%, which has not improved much in the past 30 years. Even though the majority of women have successful initial therapy, the low rate of survival is due to the eventual recurrence and succumbing to their disease. With the recent release of the Cancer Genome Atlas for ovarian cancer, it was shown that the PI3K/AKT/mTOR pathway was one of the most frequently mutated or altered pathways in patients’ tumors. Researching how the PI3K/AKT/mTOR pathway affects the progression and tumorigensis of ovarian cancer will hopefully lead to new therapies that will increase survival for women. This review focuses on recent research on the PI3K/AKT/mTOR pathway and its role in the progression and tumorigensis of ovarian cancer. View Full-Text
Keywords: ovarian cancer; PI3K; mTOR; AKT ovarian cancer; PI3K; mTOR; AKT
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Dobbin, Z.C.; Landen, C.N. The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer. Int. J. Mol. Sci. 2013, 14, 8213-8227.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top